A new treatment for AMD: references

Article

References

1. The World Health Organization. The World Health Report 2002-Reducing Risks, Promoting Healthy Life, pp 47-96. From the Internet @ www.who.int/whr/2002, accessed March 18, 2008.

2. National Institute for Health and Clinical Excellence (NICE). Incorporating health economics in guidelines and assessing resource impact. The Guidelines Manual, London, NICE, 2007, Chap 8. Available on the Internet @www.nice.org.uk, accessed 3-15-08.

3. Bureau of Labor and Statistics. Data on disability and unemployment. 1991/92, 1993/94, 1994/95, and 1997. From the Survey of Income and Program Participation. From the Internet @ www.bls.census.gov, accessed April 4, 2008.

4. Political calculations. Average wages in the US. http://politicalcalculations.blogspot.com, accessed 4-6-08.

5. Macular Degeneration Partnership. Available at: www.AMD.org. Accessed August 14, 2009.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
© 2024 MJH Life Sciences

All rights reserved.